These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38915689)

  • 1. Adjuvant Delivery Method and Nanoparticle Charge Influence Peptide Amphiphile Micelle Vaccine Bioactivity.
    Zhang R; Rygelski BT; Kruse LE; Smith JD; Wang X; Allen BN; Kramer JS; Seim GF; Faulkner TJ; Kuang H; Kokkoli E; Schrum AG; Ulery BD
    bioRxiv; 2024 Oct; ():. PubMed ID: 38915689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide Amphiphile Micelle Vaccine Size and Charge Influence the Host Antibody Response.
    Zhang R; Smith JD; Allen BN; Kramer JS; Schauflinger M; Ulery BD
    ACS Biomater Sci Eng; 2018 Jul; 4(7):2463-2472. PubMed ID: 33435110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
    Zhang R; Kramer JS; Smith JD; Allen BN; Leeper CN; Li X; Morton LD; Gallazzi F; Ulery BD
    AAPS J; 2018 Jun; 20(4):73. PubMed ID: 29858738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modular Peptide Amphiphile Micelles Improving an Antibody-Mediated Immune Response to Group A Streptococcus.
    Barrett JC; Ulery BD; Trent A; Liang S; David NA; Tirrell MV
    ACS Biomater Sci Eng; 2017; 3(2):144-152. PubMed ID: 29242824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cationic Micelle Complex Improves CD8+ T Cell Responses in Vaccination Against Unmodified Protein Antigen.
    Brubaker CE; Panagiotou V; Demurtas D; Bonner DK; Swartz MA; Hubbell JA
    ACS Biomater Sci Eng; 2016 Feb; 2(2):231-240. PubMed ID: 33418636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide Amphiphile Micelles for Vaccine Delivery.
    Barrett JC; Tirrell MV
    Methods Mol Biol; 2018; 1798():277-292. PubMed ID: 29868967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide amphiphile micelles self-adjuvant group A streptococcal vaccination.
    Trent A; Ulery BD; Black MJ; Barrett JC; Liang S; Kostenko Y; David NA; Tirrell MV
    AAPS J; 2015 Mar; 17(2):380-8. PubMed ID: 25527256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy.
    Luo Z; Li P; Deng J; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
    J Control Release; 2013 Sep; 170(2):259-67. PubMed ID: 23742880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micelle-Based Adjuvants for Subunit Vaccine Delivery.
    Trimaille T; Verrier B
    Vaccines (Basel); 2015 Sep; 3(4):803-13. PubMed ID: 26426060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
    Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
    J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentablock Copolymer Micelle Nanoadjuvants Enhance Cytosolic Delivery of Antigen and Improve Vaccine Efficacy while Inducing Low Inflammation.
    Senapati S; Darling RJ; Loh D; Schneider IC; Wannemuehler MJ; Narasimhan B; Mallapragada SK
    ACS Biomater Sci Eng; 2019 Mar; 5(3):1332-1342. PubMed ID: 33405651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-adjuvants and immune agonists promote antitumor immunity of peptide amphiphiles.
    Yan H; Lin G; Liu Z; Gu F; Zhang Y
    Acta Biomater; 2023 Apr; 161():213-225. PubMed ID: 36858163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative Vaccine Strategy: Self-Adjuvanting Conjugate Vaccines.
    Manabe Y; Fukase K
    Methods Mol Biol; 2023; 2613():55-72. PubMed ID: 36587070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in self-adjuvanting glycoconjugate vaccines.
    Manabe Y; Chang TC; Fukase K
    Drug Discov Today Technol; 2020 Dec; 37():61-71. PubMed ID: 34895656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of component structural arrangement on peptide vaccine immunogenicity.
    Alharbi N; Skwarczynski M; Toth I
    Biotechnol Adv; 2022 Nov; 60():108029. PubMed ID: 36028180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive Intestinal Peptide Amphiphile Micelle Chemical Structure and Hydrophobic Domain Influence Immunomodulatory Potentiation.
    Wang X; Zhang R; Lindaman BD; Leeper CN; Schrum AG; Ulery BD
    ACS Appl Bio Mater; 2022 Apr; 5(4):1464-1475. PubMed ID: 35302343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.
    Nakagawa T; Tanino T; Onishi M; Tofukuji S; Kanazawa T; Ishioka Y; Itoh T; Kugimiya A; Katayama K; Yamamoto T; Nagira M; Ishii KJ
    Front Immunol; 2021; 12():803090. PubMed ID: 35003132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.
    Nevagi RJ; Khalil ZG; Hussein WM; Powell J; Batzloff MR; Capon RJ; Good MF; Skwarczynski M; Toth I
    Acta Biomater; 2018 Oct; 80():278-287. PubMed ID: 30266637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.